Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07706673
PHASE4

ESCUDDO Long Term Follow Up

Sponsor: National Cancer Institute (NCI)

View on ClinicalTrials.gov

Summary

This phase IV trial evaluates the long term protection provided by either one or two doses of the 9v human papillomavirus (HPV) vaccine for participants who were part of the ESCUDDO study.

Official title: A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study ("Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano (VPH)")

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

13700

Start Date

2026-08-11

Completion Date

2031-01-15

Last Updated

2026-09-22

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

Given IM in ESCUDDO (NCT03180034)

BIOLOGICAL

Recombinant Human Papillomavirus Nonavalent Vaccine

Given intramuscularly (IM) in ESCUDDO (NCT03180034)

Locations (1)

Agencia Costarricense de Investigaciones Biomédicas (ACIB)

Liberia, Guanacaste Province, Costa Rica